We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants

By LabMedica International staff writers
Posted on 17 Oct 2022
Print article
Image: The BD Veritor System for Rapid Detection of SARS‑CoV‑2 antigen test detects nucleoproteins from the SARS‑CoV‑2 virus in as little as 15 minutes, and can be conducted at the point-of-care (Photo courtesy of Becton, Dickinson and Company)
Image: The BD Veritor System for Rapid Detection of SARS‑CoV‑2 antigen test detects nucleoproteins from the SARS‑CoV‑2 virus in as little as 15 minutes, and can be conducted at the point-of-care (Photo courtesy of Becton, Dickinson and Company)

Accurate and accessible testing for SARS-CoV-2 is a critical tool for the timely identification of infection to inform isolation recommendations, prevent transmission, and facilitate early initiation of therapy to reduce disease progression.

Rapid antigen tests for COVID-19 show great promise as a testing method that is easy to use, accessible, and cost-effective Rapid antigen tests (Ag-RDTs) have lower sensitivity than RT-PCR tests for detecting SARS-CoV-2, however, sensitivity can be improved through serial testing.

A large team of medical scientists at the University of Massachusetts Chan Medical School, Worcester, MA, USA) compared the performance of Ag-RDTs in detecting the Delta (B.1.617.2) and Omicron (B.1.1.529) variants of SARS-CoV-2. The team relied on data from the prospective cohort study Test Us At Home in which participants serially took both at-home antigen and send-in PCR COVID-19 tests over a period of 10 to 15 days. This analysis focuses on the 5,779 individuals who tested negative for SARS-CoV-2 at the start of the parent study and the 207 individuals of those who later tested positive for the virus by PCR.

On enrollment, participants were assigned to 1 of 3 Ag-RDTs with emergency use authorization: BD Veritor At-Home COVID-19 Test (Becton, Dickinson and Company, San Diego, CA, USA), Quidel QuickVue At-Home OTC COVID-19 Test (San Diego, CA, USA) and Abbott BinaxNOW COVID-19 Antigen Self-Test (Princeton, NJ, USA). Participants received the Ag-RDT and the Quest Diagnostics collection kit for COVID-19 by mail at the shipping address provided on enrollment.

The investigators reported that a total of 207 participants were positive on RT-PCR (58 Delta, 149 Omicron). Differences in sensitivity between variants were not statistically significant (same day: Delta, 15.5% [95% CI, 6.2% to 24.8%] versus Omicron, 22.1% [CI, 15.5% to 28.8%]; at 48 hours: Delta, 44.8% [CI, 32.0% to 57.6%] versus Omicron, 49.7% [CI, 41.6% to 57.6%]). Among 109 participants who had RT-PCR–positive results for 48 hours, rapid antigen sensitivity did not differ significantly between Delta- and Omicron-infected participants (48-hour sensitivity: Delta, 81.5% [CI, 66.8% to 96.1%] versus Omicron, 78.0% [CI, 69.1% to 87.0%]). Only 7.2% of the 69 participants with RT-PCR–positive results for shorter than 48 hours tested positive by Ag-RDT within one week; those with Delta infections remained consistently negative on Ag-RDTs.

The authors concluded that nasal swab Ag-RDT performance was similar between the Omicron and Delta variants. In both cases, detection of virus with Ag-RDTs was associated with relative viral load as measured by Ct value. The data suggest that serial testing continues to be important in improving the performance of Ag-RDTs. Future work to increase the understanding of persons with singleton RT-PCR positivity is needed to determine the public health significance of a false-negative Ag-RDT result in this subpopulation. The study was published on October 11, 2022 in the journal Annals of Internal Medicine.

Related Links:
University of Massachusetts Chan Medical School
Becton, Dickinson and Company
Quidel 
Abbott 

Gold Supplier
Sample Transport
VACUETTE Transport Line
New
Silver Supplier
Auto Molecular Diagnostic System
ELITe InGenius
New
Gold Supplier
PCR Microplate
SAPPHIRE MICROPLATE
New
Pipetting Workstation
Microlab NIMBUS

Print article

Channels

Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more

Pathology

view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more

Technology

view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more

Industry

view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.